Microbix Biosystems (TSE:MBX) Trading Down 3.8% on Insider Selling

Microbix Biosystems Inc. (TSE:MBXGet Free Report) shares fell 3.8% during mid-day trading on Thursday following insider selling activity. The stock traded as low as C$0.49 and last traded at C$0.50. 188,134 shares traded hands during trading, a decline of 36% from the average session volume of 294,601 shares. The stock had previously closed at C$0.52.

Specifically, Director Cameron Lionel Groome sold 200,000 shares of the stock in a transaction that occurred on Wednesday, January 22nd. The shares were sold at an average price of C$0.43, for a total value of C$86,500.00.

Microbix Biosystems Price Performance

The stock has a market capitalization of C$66.98 million, a PE ratio of 12.25 and a beta of 0.34. The company has a quick ratio of 5.57, a current ratio of 6.62 and a debt-to-equity ratio of 22.68. The stock’s 50-day moving average is C$0.38 and its 200 day moving average is C$0.35.

About Microbix Biosystems

(Get Free Report)

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.

Featured Stories

Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.